Selatogrel (ACT-246475) is a reversible and selective P2Y 12 receptor antagonist which inhibits platelet aggregation with an IC 50 of 8 nM. Selatogrel exhibits antithrombotic efficacy.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > P2Y Receptor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。